PKD1 inhibits cancer cells migration and invasion via Wnt signaling pathway in vitro

Cell Biochemistry and Function

Volumn 25, Issue 6, 2007, Pages 767-774

  Zhang, Ke ^a   Ye, Chun ^a   Zhou, Qin ^a   Zheng, Rong ^a   Lv, Xiaoyan ^a   Chen, Ye ^a   Hu, Zhongguo ^a   Guo, Hong ^a   Zhang, Zheng ^a   Wang, Yidong ^a   Tan, Ruizhi ^a   Liu, Yuhang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cell migration; Invasion; PKD1 gene; Wnt signaling pathway

Indexed keywords

POLYCYSTIN 1; WNT PROTEIN; BETA CATENIN; CADHERIN; COMPLEMENTARY DNA; FRZB PROTEIN; GLYCOPROTEIN; POLYCYSTIC KIDNEY DISEASE 1 PROTEIN; POLYCYSTIN; UNCLASSIFIED DRUG; WNT1 PROTEIN;

ARTICLE; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL AGGREGATION; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CELL ADHESION; CELL AGGREGATION; CELL LINE, TUMOR; CELL MOVEMENT; DNA, COMPLEMENTARY; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; SIGNAL TRANSDUCTION; TRANSFECTION; TRPP CATION CHANNELS; WNT1 PROTEIN;

EID: 38449094850     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1417     Document Type: Article

References (33)

1. Bacallao RL, Carone FA. Recent advances in the understanding of polycystic kidney disease. Curr Opin Nephrol Hypertens 1997; 6: 377-383.
2. Murcia NS, Sweeney WE, Jr, Avner ED. New insights into the molecular pathophysiology of polycystic kidney disease. Kidney Int 1999; 55: 1187-1197.
3. Wilson PD. Polycystic kidney disease: new understanding in the pathogenesis. Int J Biochem Cell Biol 2004; 36: 1868-1873.
4. Delmas P. Polycystins: polymodal receptor/ion-channel cellular sensors. Pflugers Arch 2005; 451: 264-276.
5. Bhunia AK, Piontek K, Boletta A, et al. PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 2002; 109: 157-168.
6. Vandorpe DH, Wilhelm S, Jiang L, et al. Cation channel regulation by COOH-terminal cytoplasmic tail of polycystin-1: mutational and functional analysis. Physiol Genomics 2002; 8: 87-98.
7. Boletta A, Qian F, Onuchic LF, et al. Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. Mol Cell 2000; 6: 1267-1273.
8. Vandorpe DH, Chernova MN, Jiang L, et al. The cytoplasmic C-terminal fragment of polycystin-1 regulates a Ca2+-permeable cation channel. J Biol Chem 2001; 276: 4093-4101.
9. Parnell SC, Magenheimer BS, Maser RL, Zien CA, Frichant A-M, Calvet JP. Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins. J Biol Chem 2002; 277: 19566-19572.
10. Boletta A, Qian F, Onuchic LF, et al. Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. Mol Cell 2000; 6: 1267-1273.
11. Boletta A, Germino GG. Role of polycystins in renal tubulogenesis. Trends Cell Biol 2003; 13: 484-492.
12. Giuliani N, Colla S, Morandi F, et al. Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation. Blood 2005; 106: 2472-2483.
13. Wilson PD. Polycystin: new aspects of structure, function, and regulation. J Am Soc Nephrol 2001; 12: 834-845.
14. Hughes J, Ward C, Peral B, et al. The polycystic kidney disease 1(PKD1) gene encodes a novel protein with multiple cell recognition domains. Nature Genet 1995; 10: 151-160.
15. Bycroft M, Bateman A, Clarke J, et al. The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease. EMBO J 1999; 18: 297-305.
16. Van AJ. Peptides from the PKD repeats of polycystin, the PKD1 gene product, modulate pattern formation in the developing kidney. Dev Genet 1999; 24: 299-308.
17. Geng L, Burrow CR, Li HP, Wilson PD. Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. Biochim Biophys Acta 2000; 1535: 21-35.
18. Parnell SC, Magenheimer BS, Maser RL, et al. The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem Biophys Res Commun 1998; 251: 625-631.
19. Delmas P, Nomura H, Li X, et al. Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J Biol Chem 2002; 277: 11276-11283.
20. Streets AJ, Newby LJ, O'hare MJ, Bukanov NO, Ibraghimov-Beskrovnaya O, Ong AC. Functional analysis of PKD1 transgenic lines reveals a direct role for polycystin-1 in mediating cell-cell adhesion. J Am Soc Nephrol 2003; 14: 1804-1815.
21. Ibraghimov-Beskrovnaya O, Bukanov NO, Donohue LC, Dackowski WR, Klinger KW, Landes GM. Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1. Hum Mol Genet 2000; 9: 1641-1649.
22. Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 2003; 94: 575-581.
23. Byrne RR, Shariat SF, Brown R, et al. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup. J Urol 2001; 165: 1473-1479.
24. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-185.
25. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190-193.
26. Huan Y, Van AJ. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Invest 1999; 104: 1459-1468.
27. Parnell SC, Magenheimer BS, Maser RL, Calvet JP. Identification of the major site of in vitro PKA phosphorylation in the polycystin-1 C-terminal cytosolic domain. Biochem Biophys Res Commun 1999; 259: 539-543.
28. Kim E, Arnould T, Sellin LK, et al. The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem 1999; 274: 4947-4953.
29. Le NH, Van der WA, Van der BP, et al. Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2005; 16: 2724-2731.
30. Joly D, Ishibe S, Nickel C, Yu Z, Somlo S, Cantley LG. The polycystin 1-C-terminal fragment stimulates ERK-dependenl spreading of renal epithelial cells. J Biol Chem 2006; 281: 26329-26339.
31. Nishio S, Hatano M, Nagata M, et al. PKD1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. J Clin Invest 2005; 115: 910-918.
32. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and Cadherin pathways. Science 2004; 303: 1483-1487.
33. Hinck L, Nathke IS, Papkoff J, Nelson WJ. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 1994; 125: 1327-1340.